ArticleBMC infectious diseases2026
SARS-CoV-2 intra-host viral diversity associated with host innate and vaccine-induced immunity in an obese mouse model.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundObesity associated immune dysfunction is attributed to severe outcome of infectious diseases including Coronavirus Disease 2019 (COVID-19) and suboptimal vaccine responses.
methodsUtilizing diet-induced obese (DIO) mice vaccinated with COVID-19 mRNA vaccine, we investigated SARS-CoV-2 Omicron BA.1 variant intra-host mutation under the influence of different host immune states with or without vaccination. SARS-CoV-2 Omicron BA.1 infected mouse lung transcriptome and virus genome were acquired by RNA-sequencing.
resultsConsistent with previous report that COVID-19 mRNA vaccine failed to induced serum neutralizing antibody but boosted host innate immunity upon virus challenge. At 2 days after virus challenging, the interferon and antiviral related genes were upregulated in the lungs of lean mice (regular weight controls) and vaccinated DIO mice, but not in unvaccinated DIO mice suggesting host innate immune responses to infection was not elicited in DIO mice, which was then restored by vaccination. Analysis of viral genomes in the different lung samples showed that SARS-CoV-2 was predominately under neutral or slightly negative selection in mouse lungs irrespective of immune status. However, increased intra-host viral genomic diversity was found at later infection time and vaccination-boosted host innate antiviral status in DIO mice. In total, 59 iSNVs (intra-host single nucleotide variant) were detected from 22 viral-positive-samples, 1 to 8 iSNV sites in each sample. Among which, most of the iSNVs were detected from the lungs of COVID-19 mRNA vaccine immunized DIO mice. Correlation analysis of viral mutation and host transcriptome signatures showed that the appearance of iSNV in ORF1ab, Nucleocapsid (N) and Membrane (M) genes was associated with host innate immunity. Remarkably, the Leu176His mutation in M gene was identified in all the vaccinated obese mouse lungs whereas only in one lung at 4dpi in unvaccinated DIO, which may imply the interplay between viral mutation and host antiviral immunity in the context of obesity.
conclusionsThis study advances our comprehension of SARS-CoV-2 mutation and evolution in obese related insufficient vaccine response, highlighting the impact of immune compromised host on viral evolution.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.